Intracellular osteopontin potentiates the immunosuppressive activity of mesenchymal stromal cells
Authors:
Open Access
- 15 October 2024
- journal article
- research article
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 15 (1) , 1-18
Abstract
Mesenchymal stromal cell (MSC)-based cell therapy is a promising approach for various inflammatory disorders based on their immunosuppressive capacity. Osteopontin (OPN) regulates several cellular functions including tissue repair, bone metabolism and immune reaction. However, the biological function of OPN in regulating the immunosuppressive capacity of MSCs remains elusive. This study aims to highlight the underlying mechanism of the proinflammatory cytokines affect the therapeutic ability of MSCs through OPN. MSCs in response to the proinflammatory cytokines were collected to determine the expression profile of OPN. In vitro T-cell proliferation assays and gene editing were performed to check the role and mechanisms of OPN in regulating the immunosuppressive capacity of MSCs. Inflammatory disease mouse models were established to evaluate the effect of OPN on improving MSC-based immunotherapy. We observed that OPN, including its two isoforms iOPN and sOPN, was downregulated in MSCs upon proinflammatory cytokine stimulation. Interestingly, iOPN, but not sOPN, greatly enhanced the immunosuppressive activity of MSCs on T-cell proliferation and thus alleviated the inflammatory pathologies of hepatitis and colitis. Mechanistically, iOPN interacted with STAT1 and mediated its deubiquitination, thereby inducing the master immunosuppressive mediator inducible nitric oxide synthase (iNOS) in MSCs. In addition, iOPN expression was directly downregulated by activated STAT1, which formed a negative feedback loop to restrain MSC immunosuppressive capacity. Our findings demonstrated that iOPN expression modulation in MSCs is a novel strategy to improve MSC-based immunotherapy.Keywords
Funding Information
- National Natural Science Foundation of China (82271589, 82300584, 82000567, 82000553, 82001739, 82070191, 82071727)
- National Key R&D Program of China (2018YFA010720)
This publication has 45 references indexed in Scilit:
- Angiogenic factor AGGF1 acts as a tumor suppressor by modulating p53 post-transcriptional modifications and stability via MDM2Cancer Letters, 2020
- Role of osteopontin in dendritic cell shaping of immune responsesCytokine & Growth Factor Reviews, 2019
- Current understanding of the immunosuppressive properties of mesenchymal stromal cellsJournal of Molecular Medicine, 2019
- Unanchored K48-Linked Polyubiquitin Synthesized by the E3-Ubiquitin Ligase TRIM6 Stimulates the Interferon-IKKε Kinase-Mediated Antiviral ResponseImmunity, 2014
- An Osteopontin-Integrin Interaction Plays a Critical Role in Directing Adipogenesis and Osteogenesis by Mesenchymal Stem CellsStem Cells, 2014
- Mesenchymal Stem Cells Alleviate Bacteria-Induced Liver Injury in Mice by Inducing Regulatory Dendritic CellsHepatology, 2013
- Intracellular osteopontin (iOPN) and immunityImmunologic Research, 2010
- Osteopontin: Role in immune regulation and stress responsesCytokine & Growth Factor Reviews, 2008
- IL‐18 enhances IFN‐γ‐induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytesEuropean Journal of Immunology, 2007
- Fluid flow stimulates expression of osteopontin and bone sialoprotein by bone marrow stromal cells in a temporally dependent mannerBone, 2005